Login
$MSLE
$6.47 -$0.16 (2.34%) Live

Company Executives

Officer In this role Source
Frank Gleeson Also a director
Director, President and Chief Executive Officer
Not stated
Elizabeth Williams
Chief Financial Officer
Since 2023
3 years
Michael Rudnicki
Chief Discovery Officer
Since 2021
5 years
Phil Lambert
Chief Scientific Officer
Since 2022
4 years
Wildon Farwell
Chief Medical Officer
Since 2025
1 year

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Board of Directors

From the 40-F annual report

Directors
9
serving now
Independent
3 of 3
stated in the proxy; 6 not stated
Average tenure
4.8 years
from year joined
CEO also chairs the board
No
Geoff MacKay
Director On board Independent Committees Pay Source
Geoff MacKay
2018
8 years
Not stated
Compensation Committee · Chair
Not stated
Frank Gleeson
2012
14 years
Not stated None stated Paid as CEO
Selwyn Ho
2025
1 year
Independent
Audit Committee Nominating and Corporate Governance Committee
Not stated
Iris Loew-Friedrich
2025
1 year
Not stated
Nominating and Corporate Governance Committee
Not stated
Brian Bloom
2018
8 years
Not stated None stated Not stated
Mark Nawacki
2025
1 year
Not stated None stated Not stated
Adam Mostafa
2021
5 years
Independent
Audit Committee · Chair Compensation Committee
Not stated
Franklin Berger
2023
3 years
Not stated
Nominating and Corporate Governance Committee · Chair
Not stated
Stephanie Brown
2024
2 years
Independent
Audit Committee Compensation Committee
Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No proxy statement on record

Related-party transactions come from the company’s proxy statement. Satellos Bioscience Inc. has not filed one with the SEC.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support